Moderna beats Pfizer among two-dose COVID vaccine recipients aged 60 and over, study shows

The mRNA COVID-19 vaccines developed by Pfizer and Moderna continue to save lives. But a new paper published in the journal Vaccines provides evidence that the two vaccines are not equivalent when it comes to protecting older adults against death.

This post was originally published on this site

Lawyers Lookup -